Les
Articles du mois

Publications médicales et scientifiques récentes des Médecins du Service d'Ophtalmologie de l'Hôpital Lariboisière

Couturier, A., C. M. Gemmy Cheung, R. Spaide and K. Ohno-Matsui Ophthalmology Retina , Sept 2026.
doi: 10.1016/j.oret.2026.08.009

La maculopathie tractionnelle myopique (MTM) nécessite une nomenclature standardisée pour améliorer son diagnostic et sa prise en charge. Un consensus international d’experts a élaboré une classification anatomique fondée sur les données récentes de l’OCT. Quatre…

Lire plus…
Lam, M., E. Philippakis, A. Erginay, A. Gaudric and A. Couturier (2026).
10.1038/s41433-026-04857-8.

Cette étude compare les résultats anatomiques après chirurgie de trois pathologies maculaires : le trou maculaire lamellaire (TML), la fovéoschisis lié à une membrane épirétinienne (FS-MER) et le pseudotrou maculaire (PTM). Elle porte sur 83…

Lire plus…

Autres
articles récents

Nos médecins ont publié
en 2024 et 2026

  1. Zola, M., et al., Steroidome Dysregulation and Complement C4 Copy Number Variation in Men With Central Serous Chorioretinopathy. Invest Ophthalmol Vis Sci, 2026. 67(6): p. 5.
  2. Xavier, C., et al., Bilateral Giant Pigment Epithelial Detachments and Unilateral RPE Tear and Exudative Retinal Detachment After Tadalafil Exposure: Case Report and Review of the Literature. Retin Cases Brief Rep, 2026.
  3. Vallino, V., et al., Peripapillary Choroidal Neovascularization in Adults: Spectrum of Etiologies and Clinical Features. Invest Ophthalmol Vis Sci, 2026. 67(5): p. 29.
  4. Unger, L., et al., En face localization of retinal telangiectatic capillaries using OCT compared with ICG angiography in chronic vascular macular oedema. Acta Ophthalmol, 2026.
  5. Torres-Villaros, H., et al., Telemedicine-based diabetic retinopathy screening in patients over 70 Years: a French cohort study within the OPHDIAT network. Diabetes Metab, 2026. 52(2): p. 101728.
  6. Spaide, R.F., et al., ICON-PM: International consensus on nomenclature for adult pathologic myopia. Prog Retin Eye Res, 2026. 114: p. 101495.
  7. Sahoo, N.K., et al., Clinical variations and outcomes of central serous chorioretinopathy in Black and White patients: MICRoN report-16. Retina, 2026.
  8. Romano, M.R., et al., Consensus Recommendations on the use of PFAS-containing ocular endotamponades. Ophthalmologica, 2026: p. 1-20.
  9. Papart, S., et al., Atypical Presentation of Eales Disease in a Young Woman. Retin Cases Brief Rep, 2026.
  10. Motloch, K., et al., Multimodal imaging for quantifying atrophic lesions in pathologic myopia. Eye (Lond), 2026. 40(9): p. 1399-1407.
  11. Mafi, M., et al., RPE microrips within pigment epithelial detachments colocalize with focal leakage in acute central serous chorioretinopathy. Can J Ophthalmol, 2026.
  12. Lenoir, O., et al., Levels of circulating kidney injury markers and IL-10 identify non-critically ill patients with COVID-19 at risk of death. JCI Insight, 2026. 11(2).
  13. Leclercq, B., et al., The role of the choroidal nervous system in central serous chorioretinopathy and associated diseases. Prog Retin Eye Res, 2026. 112: p. 101468.
  14. Le Boité, H., S. Maunoury, and A. Couturier, Subretinal fluid correlates with increased macular volume in diabetic macular edema. Ophthalmologica, 2026: p. 1.
  15. Lam, M., et al., Distinct postoperative anatomical outcomes between lamellar macular holes and epiretinal membrane foveoschisis. Eye (Lond), 2026.
  16. Lai, T.Y.Y., et al., POYANG: A phase III randomized clinical trial of faricimab for choroidal neovascularization secondary to pathologic myopia: study design and rationale. Graefes Arch Clin Exp Ophthalmol, 2026. 264(1): p. 141-148.
  17. La Rosa, A., et al., Angioid streaks-related choroidal neovascularization: Clinical features, multimodal imaging-based differential diagnosis, and optimized treatment strategies. Surv Ophthalmol, 2026. 71(2): p. 309-320.
  18. Khamkhoum, S., et al., Prognostic value of foveal choroidal vascular hyperpermeability on indocyanine green angiography in central serous chorioretinopathy. Eye (Lond), 2026.
  19. Gerardy, M., et al., CHOROIDAL ISCHEMIA IN PATIENTS WITH CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME: A CASE SERIES. Retin Cases Brief Rep, 2026. 20(4): p. 568-574.
  20. Gabrielle, P.H., et al., Defining a standards framework for ophthalmology real-world data methodologies through an expert-led Delphi consensus. Eye (Lond), 2026. 40(9): p. 1342-1350.
  21. Flores-Peña, D., et al., Multimodal Characterization of Mid-phase Hyperfluorescent Plaques on Indocyanine Green Angiography in Central Serous Chorioretinopathy- MICRoN report number 27. Am J Ophthalmol, 2026.
  22. Feo, A., et al., Peripapillary pachychoroid syndrome: Clinical and imaging features, diagnostic differentiation and therapeutic strategies. Surv Ophthalmol, 2026.
  23. Feo, A., et al., Neovascular and Non-Neovascular Subretinal Fluid Associated with Angioid Streaks: Comparative Imaging Analysis with Long-Term Follow-up. Ophthalmol Retina, 2026.
  24. Dupas, B., et al., Islets persisting on OCT macular thickness map after intravitreal injections unmask telangiectatic capillaries (TelCaps) in diabetic macular edema. Graefes Arch Clin Exp Ophthalmol, 2026.
  25. Dobbels, Z., et al., Surgical intervention versus conservative management in optic disc pit maculopathy. Int J Ophthalmol, 2026. 19(10): p. 2018-2025.
  26. Dentel, A., et al., PIGMENT EPITHELIUM DETACHMENT IN SEVERE ACUTE POSTERIOR MULTIFOCAL PLACOID PIGMENT EPITHELIOPATHY. Retina, 2026. 46(10): p. 1733-1739.
  27. Del Fabbro, S., et al., Dome-shaped macula in high myopia: Prevalence and clinical characteristics in a French cohort. Acta Ophthalmol, 2026.
  28. Del Fabbro, S., et al., Pathways to Patchy Atrophy in High Myopia: Precursor Patterns, Structural Characteristics, and Long-Term Outcomes. Ophthalmol Sci, 2026. 6(7): p. 101244.
  29. Cuzzubbo, S., et al., Optic neuropathies induced by immune checkpoint inhibitors: A case series and systematic review of the literature. Eur J Cancer, 2026. 237: p. 116594.
  30. Couturier, A., et al., Myopic Traction Maculopathy: consensus from the Myopia Society for a new nomenclature. Ophthalmol Retina, 2026.
  31. Coletto, A., V. Krivosic, and E. Bousquet, Arteriovenous Malformation with Central Retinal Vein Occlusion and Intraretinal Hyporeflective Spaces. Ophthalmol Retina, 2026. 10(1): p. e4.
  32. Chan, H.H., et al., TYPE 4 MACULAR NEOVASCULARIZATION: A New Member of the Optical Coherence Tomography Classification of Neovascularization Age-Related Macular Degeneration. Retina, 2026. 46(2): p. 209-219.
  33. Chambon, C., et al., Proteomic Signature in Men with Central Serous Chorioretinopathy. J Proteome Res, 2026. 25(3): p. 1761-1774.
  34. Catania, F., et al., Perforating scleral vessels in children and myopia-related pattern. Acta Ophthalmol, 2026.
  35. Carla, M.M., et al., Current advances in dome-shaped macula and associated conditions. Surv Ophthalmol, 2026. 71(2): p. 393-404.
  36. Carla, M.M., et al., Vitreoretinal interface abnormalities in age-related macular degeneration: Prevalence, pathophysiology, and reciprocal influence. Surv Ophthalmol, 2026. 71(2): p. 321-333.
  37. Carla, M.M., et al., Optical Coherence Tomography Predictive Biomarkers for Visual Outcomes after Macula-Off Rhegmatogenous Retinal Detachment: A Systematic Review and Meta-Analysis. Am J Ophthalmol, 2026. 281: p. 650-665.
  38. Canizares, L., et al., Incidence and risk factors of full-thickness macular hole in fellow eyes. Ophthalmol Retina, 2026.
  39. Callet, M., et al., Turning the Angle: Vertical Scans Improve Chorioretinal Fold Detection-Comparative Evaluation of B-scan Directions for Chorioretinal Folds in SD-OCT. Ophthalmic Surg Lasers Imaging Retina, 2026. 57(3): p. 174-177.
  40. Bousquet, E., et al., Hydroxychloroquine Retinopathy in a 23-Year-Old Man. Retin Cases Brief Rep, 2026. 20(1): p. 1-4.
  41. Bijon, J., et al., Peripheral retinal lesions in highly myopic children: prevalence, types and biometric correlates. Br J Ophthalmol, 2026. 110(6): p. 669-675.
  42. Amoroso, F., et al., SD-OCT and OCTA: distinct or additional information on neovascular activity? The COCTAEYL Study. Retina, 2026.
  43. Zureik, A., A. Couturier, and C. Delcourt, Evolution of ophthalmological care in adult with diabetes in France between 2010 and 2022: a nationwide study. Graefes Arch Clin Exp Ophthalmol, 2025.
  44. Zeghlache, R., et al., L-MAE: Longitudinal masked auto-encoder with time and severity-aware encoding for diabetic retinopathy progression prediction. Comput Biol Med, 2025. 185: p. 109508.
  45. Voichanski, S., et al., En Face OCT and the Phenotype Characterization of Drusen. Invest Ophthalmol Vis Sci, 2025. 66(9): p. 52.
  46. Vienne-Jumeau, A., et al., Choroidal neovascularization as a trigger for central serous chorioretinopathy. Int J Retina Vitreous, 2025.
  47. Vienne-Jumeau, A., E. Bousquet, and F. Behar-Cohen, Complement system modulation in age-related macular degeneration: navigating failures, building future successes. Curr Opin Immunol, 2025. 96: p. 102616.
  48. Verstraete, M.J., et al., Abinit 2025: New capabilities for the predictive modeling of solids and nanomaterials. J Chem Phys, 2025. 163(16).
  49. Touhami, S., et al., Acute Angioid Streak Retinopathy is a Two-Phase Inflammatory Process Starting with Outer Retinal Inflammation, Followed by Secondary MEWDS. Ocul Immunol Inflamm, 2025: p. 1-4.
  50. Tahhan, N., et al., IMI-2025 Digest. Invest Ophthalmol Vis Sci, 2025. 66(12): p. 27.
  51. Souied, E.H., et al., Functional and anatomic outcomes of brolucizumab in adults with neovascular age-related macular degeneration – The OCTOPUS cohort study. J Fr Ophtalmol, 2025. 48(7): p. 104583.
  52. Santina, A., et al., Pentosan polysulfate sodium maculopathy: Final analysis of a prospective cohort, updated review, and association with inflammatory bowel disease. Surv Ophthalmol, 2025. 70(3): p. 583-592.
  53. Nesper, P.L., et al., Baseline Photoreceptor and Vascular Abnormalities on OCT Angiography Predict Disease Progression in Early Macular Telangiectasia Type 2. Ophthalmol Retina, 2025.
  54. Moukadem, O., et al., Incidence and Enlargement Rate of Myopic Macular Neovascularization-Related Atrophy in Highly Myopic Eyes. Retina, 2025.
  55. Morel, J.B., et al., Ten-year follow-up of Fluid Fluctuations in a Patient with Optic Disc Pit Maculopathy. Retin Cases Brief Rep, 2025.
  56. McLoughlin, C., et al., An Exploration of How Functional Neurological Disorder Is Discussed on X (Twitter): Mixed Methods Study Using Social Network and Content Analysis. J Med Internet Res, 2025. 27: p. e73439.
  57. McGuire, J.A., et al., Comparison of Physical Aging and Glass Transition in Glassy-Rubbery Polymer Bilayer Films. J Phys Chem B, 2025. 129(10): p. 2778-2788.
  58. Mafi, M., et al., Pathogenesis of Ectopic Inner Foveal Layers (EIFL) and Its Impact on Visual Recovery after Epiretinal Membrane Peeling. Retina, 2025.
  59. Lejoyeux, R., et al., Genetic analysis of participants with foveal hypoplasia. Ophthalmic Genet, 2025: p. 1-4.
  60. Lejoyeux, R., et al., Prevalence and significance of fovea plana in patients with epiretinal membrane. Eur J Ophthalmol, 2025. 35(2): p. 645-649.
  61. Le Divenah, N., et al., Epidemiological disparities in pulmonary sarcoidosis between public and private healthcare sectors in haute-Garonne department (France). Respir Med Res, 2025. 88: p. 101177.
  62. Le Boite, H., et al., Deep learning for retinal non-perfusion and foveal avascular zone analysis in wide-field OCTA in diabetic retinopathy. Sci Rep, 2025. 15(1): p. 30225.
  63. Lai, T.Y.Y., et al., POYANG: A phase III randomized clinical trial of faricimab for choroidal neovascularization secondary to pathologic myopia: study design and rationale. Graefes Arch Clin Exp Ophthalmol, 2025.
  64. La Rosa, A., et al., Angioid streaks-related choroidal neovascularization: Clinical features, multimodal imaging-based differential diagnosis, and optimized treatment strategies. Surv Ophthalmol, 2025.
  65. Krivosic, V., et al., Assessment of Retinal Arteriolar Tortuosity in Patients with Col4a1 or Col4a2 Mutations. Retina, 2025. 45(2): p. 296-302.
  66. Khanani, A.M., et al., Effect of Brolucizumab and Aflibercept on the Maximum Thickness of Pigment Epithelial Detachments and Sub-Retinal Pigment Epithelium Fluid in HAWK and HARRIER. Ophthalmol Retina, 2025. 9(1): p. 13-21.
  67. Issa, M., et al., Applications of artificial intelligence to inherited retinal diseases: A systematic review. Surv Ophthalmol, 2025. 70(2): p. 255-264.
  68. Higue, J., et al., Venetoclax and azacitidine for molecular relapse after intensive chemotherapy in NPM1 or CBF AML: a FILO study. Blood Cancer J, 2025. 15(1): p. 141.
  69. Gualino, V., et al., Real-world faricimab switch in France: artificial intelligence-based detection of changes in exudative signs in difficult-to-treat neovascular age-related macular degeneration. BMJ Open Ophthalmol, 2025. 10(1).
  70. Gerardy, M., et al., Choroidal Ischemia in patients with Catastrophic Antiphospholipid Syndrome: a case series. Retin Cases Brief Rep, 2025.
  71. Garcin, T., et al., Internal Limiting Membrane Peeling for Large Macular Holes Induces Only Structural Remodeling without Functional Impairment Over 12 Years. Ophthalmol Retina, 2025. 9(3): p. 253-262.
  72. Fava, M., A.H. Romero, and E. Bousquet, Handedness Selection and Hysteresis of Chiral Orders in Crystals. Phys Rev Lett, 2025. 135(14): p. 146102.
  73. Couturier, A.A. and C.B. Roth, Impact of Domain Size on the Length Scale of Local Glass Transition Perturbations Caused by an Immiscible Glassy-Rubbery Interface. ACS Macro Lett, 2025. 14(9): p. 1256-1262.
  74. Couturier, A., et al., Anatomic biomarkers as potential endpoints in diabetic macular edema: A systematic literature review with identification of macular volume as a key surrogate for visual acuity. Surv Ophthalmol, 2025.
  75. Couturier, A., et al., Disease control, visual and anatomic outcomes at week 48 of brolucizumab treatment in patients with previously suboptimal anatomically controlled neovascular age-related macular degeneration – The SWIFT study. J Fr Ophtalmol, 2025. 48(7): p. 104574.
  76. Couturier, A., et al., Evaluation of the performance and safety of adding the iron chelator MEX-CD1 to dialysate during continuous veno-venous haemodialysis for removing excess labile iron in intensive care patients with sepsis-associated acute kidney injury – the Iron in Intensive Care trial (IRON-I.C.): protocol for a phase I-II randomised crossover pilot study. BMJ Open, 2025. 15(12): p. e109783.
  77. Couturier, A., N. Fraikin, and C. Lesterlin, Exclusion systems preserve host cell homeostasis and fitness, ensuring successful dissemination of conjugative plasmids and associated resistance genes. Nucleic Acids Res, 2025. 53(17).
  78. Chung, Y.R., et al., Idiopathic Photoreceptoritis: An Unusual Variant of Outer Retinopathy. Ocul Immunol Inflamm, 2025: p. 1-4.
  79. Chew, E.Y., et al., Cell-Based Ciliary Neurotrophic Factor Therapy for Macular Telangiectasia Type 2. NEJM Evid, 2025. 4(8): p. EVIDoa2400481.
  80. Chan, H.H., et al., Type 4 Macular Neovascularization (NV): A New Member of the Optical Coherence Tomography (OCT) Classification of NV Age-Related Macular Degeneration (AMD). Retina, 2025.
  81. Carla, M.M., et al., Current advances in dome-shaped macula and associated conditions. Surv Ophthalmol, 2025.
  82. Carla, M.M., et al., Vitreoretinal interface abnormalities in age-related macular degeneration: Prevalence, pathophysiology, and reciprocal influence. Surv Ophthalmol, 2025.
  83. Carla, M.M., et al., Influence of posterior staphyloma morphology on macular hole closure patterns in highly myopic eyes. Acta Ophthalmol, 2025.
  84. Carla, M.M., et al., The influence of scleral buckle on choroidal architecture: An unexplored link with the spectrum of acquired overload choroidopathy? Surv Ophthalmol, 2025. 70(6): p. 1181-1190.
  85. Bijon, J., et al., Advanced protocol for myopia management in paediatric & adolescent populations. Eye (Lond), 2025.
  86. Benchimol, A., et al., Surgical outcomes of vitrectomy with gas or silicone oil tamponade for giant retinal tears. Ophthalmologica, 2025: p. 1-22.
  87. Benahmed, R., et al., Perivascular Chorioretinal Atrophy: An Unusual Feature in Pathologic Myopia Eyes. Am J Ophthalmol, 2025. 271: p. 498-506.
  88. Arandilla, A., E. Bousquet, and P. Goupillou, Wide-Field Imaging of a Large Retinal Cavernous Hemangioma in a 13-Year-Old Boy. Ophthalmol Retina, 2025.
  89. Antropoli, A., et al., Extensive macular atrophy with pseudodrusen-like appearance (EMAP) clinical characteristics, diagnostic criteria, and insights from allied inherited retinal diseases and age-related macular degeneration. Prog Retin Eye Res, 2025. 104: p. 101320.
  90. Abdelmassih, Y., et al., Early reperfusion in patients with acute retinal artery occlusion: A multicenter prospective study. International Journal of Stroke, 2025. 20(3): p. 338-346.
  91. Voichanski, S., et al., En Face Optical Coherence Tomography Illustrates the Trizonal Distribution of Drusen and Subretinal Drusenoid Deposits in the Macula. Am J Ophthalmol, 2024. 261: p. 187-198.
  92. Vienne-Jumeau, A., et al., Corticosteroids Decrease the Incidence and Activity of Choroidal Neovascularization in Patients with Punctuate Inner Choroidopathy or Multifocal Choroiditis. Ocul Immunol Inflamm, 2024. 32(5): p. 602-608.
  93. Toumi, E., et al., Visual Outcomes after Spontaneous and Surgical Closure of Small Idiopathic Macular Holes: A Comparative Study. Ophthalmologica, 2024: p. 1-7.
  94. Torrell-Belzach, N., et al., Hemorrhagic unilateral retinopathy: a report of multimodal imaging in three cases. Retin Cases Brief Rep, 2024.
  95. Tan, T.E., et al., Imaging Modalities for Assessing the Vascular Component of Diabetic Retinal Disease: Review and Consensus for an Updated Staging System. Ophthalmol Sci, 2024. 4(3): p. 100449.
  96. Tadayoni, R., et al., Efficacy and Safety of Faricimab for Macular Edema due to Retinal Vein Occlusion: 24-Week Results from the BALATON and COMINO Trials. Ophthalmology, 2024. 131(8): p. 950-960.
  97. Tadayoni, R., et al., Artificial intelligence-based prediction of diabetic retinopathy evolution (EviRed): protocol for a prospective cohort. BMJ Open, 2024. 14(4): p. e084574.
  98. Sukkarieh, G., et al., Update on the grading of foveal hypoplasia. Int Ophthalmol, 2024. 44(1): p. 197.
  99. Souissi, S., et al., Macular oedema secondary to rhegmatogenous retinal detachment repair: risk factors for resistance to first-line therapy and long-term response to dexamethasone intravitreal implant. Eye (Lond), 2024. 38(6): p. 1155-1161.
  100. Song, D., et al., Catastrophic retinal vascular occlusion and vision loss due to crystal deposition in end-stage kidney disease treated with peritoneal dialysis. Am J Ophthalmol Case Rep, 2024. 36: p. 102153.
  101. Sharma, A., et al., RWC Update: Improving Surgical Outcomes With Intraoperative Fluorescein Angiography; Myopic Macular Holes – When to Operate?; Harada’s Disease. Ophthalmic Surg Lasers Imaging Retina, 2024. 55(1): p. 5-8.
  102. Sharma, A., et al., Anti-VEGF Biosimilars for Retinal Diseases Survey 2023- India (Bio-INDAS) by the International Retina Biosimilar Study Group (Inter-BIOS Group) in collaboration with the Vitreo-Retinal Society of India (VRSI). Eye (Lond), 2024. 38(17): p. 3392-3395.
  103. Sarraf, D., et al., Pigment Epithelial Detachment Thickness and Variability Affects Visual Outcomes in Patients with Neovascular Age-Related Macular Degeneration. Retina, 2024. 44(1): p. 10-19.
  104. Santina, A., et al., Pentosan polysulfate sodium maculopathy: Final analysis of a prospective cohort, updated review, and association with inflammatory bowel disease. Surv Ophthalmol, 2024.
  105. Santina, A., et al., Recurrent Anterior Uveitis Associated with Major Fluctuations in Choroidal Thickness in a Patient with Pachychoroid Disorder. Retin Cases Brief Rep, 2024. 18(5): p. 562-565.
  106. Sadda, S., et al., Comparative assessment of subretinal hyper-reflective material in patients treated with brolucizumab versus aflibercept in HAWK and HARRIER. Br J Ophthalmol, 2024. 108(6): p. 852-858.
  107. Sacconi, R., et al., Type 3 Macular Neovascularization in Age-related Macular Degeneration: Baseline Predictors of 3-Year Macular Atrophy Development. Ophthalmol Retina, 2024.
  108. Ramtohul, P., et al., Paracentral Acute Middle Maculopathy Associated with Severe Plasmodium Falciparum Malaria. Retin Cases Brief Rep, 2024. 18(1): p. 47-50.
  109. Paris, A., et al., Cerebro-Ocular Toxocariasis Revealed by Bilateral Cystoid Macular Edema. Ocul Immunol Inflamm, 2024. 32(1): p. 127-130.
  110. Motloch, K., et al., Efficacy and Safety of 0.19-mg Fluocinolone Acetonide Implant in Postoperative Cystoid Macular Edema after Pars Plana Vitrectomy: The ILUvien in Postoperative CYstoid Macular eDema Study. Ophthalmol Retina, 2024. 8(12): p. 1181-1191.
  111. Moleiro, A.F., et al., WHEN THE PICTURE MASKS THE DIAGNOSIS – AN ATYPICAL AND SEVERE GIANT CELL ARTERITIS CASE REPORT. Retinal Cases & Brief Reports, 2024. 18(4): p. 446-450.
  112. Lejoyeux, R., et al., Prevalence and significance of fovea plana in patients with epiretinal membrane. Eur J Ophthalmol, 2024: p. 11206721241265994.
  113. Krivosic, V., et al., From Outer Retinal Neovacularization to Exudative Subretinal Neovascularization in Macular Telangiectasia Type 2. Retina, 2024. 44(7): p. 1217-1223.
  114. Krivosic, V., et al., Assessment of retinal arteriolar tortuosity in patients with COL4A1 or COL4A2 mutations. Retina, 2024.
  115. Krivosic, V., et al., Multilayer Retinal Correspondence of the Structural and Vascular Anomalies in Eyes With Early Macular Telangiectasia Type 2. Invest Ophthalmol Vis Sci, 2024. 65(11): p. 24.
  116. Korobelnik, J.F., et al., XTEND: Two-Year Results from a Global Observational Study Investigating Proactive Dosing of Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration. Ophthalmol Ther, 2024. 13(3): p. 725-738.
  117. Khanani, A.M., et al., TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2. Ophthalmology, 2024. 131(8): p. 914-926.
  118. Issa, M., et al., A novel RLBP1 gene mutation associated to a flecked retina syndrome. Retin Cases Brief Rep, 2024.
  119. H, L.E.B., et al., VMseg: Using spatial variance to automatically segment retinal non-perfusion on OCT-angiography. PLoS One, 2024. 19(8): p. e0306794.
  120. Goudot, M., et al., Retinal and Vitreous Changes Associated with Spontaneous Improvement in Myopic Macular Schisis. Ophthalmol Retina, 2024. 8(12): p. 1192-1199.
  121. Gaudric, A., Value and Significance of Hypofluorescent Lesions Seen on Late-Phase Indocyanine Green Angiography. Ophthalmol Sci, 2024. 4(2): p. 100406.
  122. Garcin, T., et al., Internal Limiting Membrane Peeling for Large Macular Holes Induces Only Structural Remodeling without Functional Impairment Over 12 Years. Ophthalmol Retina, 2024.
  123. Fragiotta, S., et al., Vitelliform Lesions Associated with Leptochoroid and Pseudodrusen. Ophthalmol Retina, 2024. 8(12): p. 1151-1162.
  124. Fouad, Y.A., et al., Reply. Retina, 2024. 44(11): p. e74-e75.
  125. Feenstra, H.M.A., et al., Central serous chorioretinopathy: An evidence-based treatment guideline. Prog Retin Eye Res, 2024. 101: p. 101236.
  126. Estawro, R., et al., Cystoid macular edema as a complication of central retinal artery occlusion. Am J Ophthalmol Case Rep, 2024. 33: p. 101998.
  127. El Habib Daho, M., et al., DISCOVER: 2-D multiview summarization of Optical Coherence Tomography Angiography for automatic diabetic retinopathy diagnosis. Artif Intell Med, 2024. 149: p. 102803.
  128. Dupas, B., et al., Photocoagulation or sham laser in addition to conventional anti-VEGF therapy in macular edema associated with TelCaps due to diabetic macular edema or retinal vein occlusion (TalaDME): a study protocol for a multicentric, French, two-group, non-commercial, active-control, observer-masked, non-inferiority, randomized controlled clinical trial. Trials, 2024. 25(1): p. 273.
  129. Ducloyer, J.B., et al., Pros and cons of internal limiting membrane peeling during epiretinal membrane surgery: a randomised clinical trial with microperimetry (PEELING). Br J Ophthalmol, 2024. 109(1): p. 119-125.
  130. Debillon, L., et al., Birdshot Chorioretinitis in Patients Aged 80 and Older. Ocul Immunol Inflamm, 2024. 32(7): p. 1212-1217.
  131. de Saint Sauveur, G., et al., Incidence of macular displacement after rhegmatogenous retinal detachment surgery using ultra-widefield fundus autofluorescence. Int Ophthalmol, 2024. 44(1): p. 66.
  132. Danese, C., et al., The potential role and limitations of antiseptic eyedrops in ophthalmic surgery. Eur J Ophthalmol, 2024: p. 11206721241307995.
  133. Chung, Y.R., et al., Anatomical, Functional, and Prognostic Results of Vitrectomy in Epiretinal Membranes Secondary to Retinal Vein Occlusions. Ophthalmologica, 2024: p. 1-11.
  134. Cheng, J.Y., et al., ACUTE POSTERIOR MULTIFOCAL PLACOID PIGMENT EPITHELIOPATHY AND PLACOID VARIANT DISEASES MASQUERADING AS AGE-RELATED MACULAR DEGENERATION IN THE ELDERLY: A Case Series. Retina, 2024. 44(10): p. 1666-1678.
  135. Chehaibou, I., et al., Natural History and Surgical Outcomes of Lamellar Macular Holes. Ophthalmol Retina, 2024. 8(3): p. 210-222.
  136. Chatzistergiou, V., et al., Prevalence of Fovea Plana in patients with rhegmatogenous retinal detachment. Eur J Ophthalmol, 2024: p. 11206721241286125.
  137. Bousquet, E., et al., Hydroxychloroquine retinopathy in a 23-year-old male. Retin Cases Brief Rep, 2024.
  138. Bousquet, E., et al., From Drusen to Type 3 Macular Neovascularization. Retina, 2024. 44(2): p. 189-196.
  139. Bousquet, E., et al., Retinal Ischemic Perivascular Lesions Are Associated With Myocardial Infarction in Patients With Coronary Artery Disease. Am J Ophthalmol, 2024. 264: p. 224-228.
  140. Bousquet, E., et al., Sub retinal pigment epithelium hyporeflective spaces preceding large drusen collapse. Retina, 2024.
  141. Borella, Y., et al., Switching to subtenon triamcinolone acetonide does not jeopardize the functional and anatomic outcomes of dexamethasone implant treated eyes with diabetic macular edema. Graefes Arch Clin Exp Ophthalmol, 2024. 262(10): p. 3135-3142.
  142. Bonnin, S., et al., Spatially resolved imaging of human macular capillaries using adaptive optics-enhanced optical coherence tomography angiography. Sci Rep, 2024. 14(1): p. 15540.
  143. Bencheqroun, M., et al., Macular holes with minimal diameter greater than 650 microm close in 85% of cases after vitrectomy and ILM peeling with visual benefit. Eye (Lond), 2024. 38(17): p. 3341-3346.
  144. Benahmed, R., et al., Perivascular Chorioretinal Atrophy: an Unusual Feature in Pathologic Myopia Eyes. Am J Ophthalmol, 2024.
  145. Aziria, A., et al., Refractive outcomes of Carlevale IOLs compared to Artisan iris-claw IOLs considering the type of incision. Eur J Ophthalmol, 2024. 34(6): p. 1890-1898.
  146. Abraham, N., et al., Successful Treatment of Severe Peripapillary Pachychoroid Syndrome with Anti-Vascular Endothelial Growth Factor Therapy. Retin Cases Brief Rep, 2024. 18(3): p. 279-284.
  147.  

En cas d'Urgence Ophtalmologique

Une consultation sans rendez-vous est ouverte du
lundi au vendredi de 8h30 à 17 h

En dehors de ces horaires et pour les autres urgences ophtalmologiques (œil rouge, œil douloureux, traumatisme oculaire) dirigez vous vers

29 rue Manin
75019 Paris

27 rue du Fbg Saint Jacques
75014 Paris

Vous êtes un nouveau patient
et souhaitez prendre un RDV de consultation.

Les consultations spécialisées en pathologie et chirurgie de la rétine et en chirurgie de la cataracte sont accessibles avec un courrier d’un ophtalmologiste, d’un médecin généraliste ou spécialiste (SAUF URGENCE).

Consultez la liste des ophtalmologistes consultant dans le service et les jours de consultation

PRENDRE RENDEZ VOUS :